Status:
COMPLETED
IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism
Lead Sponsor:
Hospital General Ajusco Medio
Conditions:
Secondary Hyperparathyroidism
Eligibility:
All Genders
18-90 years
Brief Summary
Secondary hyperparathyroidism (SHPT) is a multisystemic syndrome that affects calcium and bone homeostasis in patients with chronic kidney disease (CKD). Despite medical treatment, 1-2% of patients re...
Detailed Description
A prospective observational study (cohort) was performed in patients who were submitted to parathyroidectomy by an endocrine surgeon for SHPT. All were submitted to a bilateral neck exploration with a...
Eligibility Criteria
Inclusion
- PTH \>800pg/mL and SHPT symptoms, or
- Asymptomatic patients with PTH \>1000pg/mL who were resistant to treatment
- compliance with the signature of the informed consent
Exclusion
- patients who respond adequately to medical treatment
- incomplete IOPTH protocol
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04484116
Start Date
July 1 2017
End Date
November 30 2019
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Ajusco Medio
Mexico City, Mexico, 14250